High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors
- 9 April 2012
- Vol. 30 (26), 3908-3917
- https://doi.org/10.1016/j.vaccine.2012.03.079
Abstract
No abstract availableKeywords
Funding Information
- University of Florida Shands Cancer Center (P01 DK-058327, R01 HL-097088, R01 GM-082946)
This publication has 50 references indexed in Scilit:
- Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cellsGene Therapy, 2011
- Activation of the NF-κB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapyProceedings of the National Academy of Sciences, 2011
- High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed TyrosinesMolecular Therapy, 2010
- An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cellsProceedings of the National Academy of Sciences, 2009
- High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype VectorsMolecular Therapy, 2009
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expressionVirology, 2008
- Adeno‐associated virus‐mediated gene transferJournal of Cellular Biochemistry, 2008
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower dosesProceedings of the National Academy of Sciences, 2008
- Replicating and non-replicating viral vectors for vaccine developmentCurrent Opinion in Biotechnology, 2007
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007